Skip to content
ppharmaranks
Menu

DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE vs RETIN-A

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE and RETIN-A are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

New
74/100

Pharmacy pays

—
$1.05 /g

Type

RX
RX

Active ingredient

DOLUTEGRAVIR AND LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
TRETINOIN

Dosage forms

Tablet
Topical

Drug class

—
Retinoid

Boxed warning

None
None

Half-life

about 14 hours
—

Treats

—
Acne Vulgaris, Facial Dermatoses, Acute Promyelocytic Leukemia

Get retin-ahigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

What is the difference between Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate and Retin-A?

Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate contains Dolutegravir and Lamivudine and Tenofovir Disoproxil Fumarate, while Retin-A contains Tretinoin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.